VRAY logo

ViewRay (VRAY) Company Overview

Profile

Full Name:

ViewRay, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

August 10, 2015

Indexes:

Not included

Website:

http://www.viewray.com

Description:

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Key Details

Price

$0.03

Market Cap

$4.59 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$102.21 M(+45.76% YoY)

Annual EPS

-$0.59(+11.94% YoY)

PE Ratio

-

Annual ROE

-85.17%

Annual Debt To Equity

0.95

Beta

-335.00

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 2, 2023

Recent annual earnings:

Feb 27, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

May 11, 23 Morgan Stanley
Equal-Weight
May 11, 23 B. Riley Securities
Neutral
Apr 24, 23 Piper Sandler
Overweight
Apr 17, 23 Jefferies
Hold
Apr 14, 23 Stifel
Hold
Apr 14, 23 Oppenheimer
Perform
Apr 14, 23 Morgan Stanley
Equal-Weight
Apr 14, 23 BTIG
Neutral
Feb 28, 23 Oppenheimer
Outperform
Nov 18, 22 Morgan Stanley
Equal-Weight

Screeners with VRAY included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.03
VRAY price is $0.03

Price All-time High

$12.44
VRAY price is currently -99.80% below its historical high of $12.44

Price Analysts Target

$1.00
VRAY price is currently -97.50% lower than the consensus analysts' forecast

Price Most Recent Change

-
VRAY price change on Feb 6, 2025 is unknown

Price YTD Change

-
VRAY price ytd change is unknown

Price 3-Year Change

-99.38%
VRAY price is down -99.38% over the past 3 years

Market cap

Market Cap

$4.59 M
VRAY market capitalization is $4.59 million

Market Cap 3-Year Change

-99.36%
VRAY market capitalization is down -99.36% over the past 3 years

Market Cap All-time High

$1.25 B
VRAY market capitalization is currently -99.63% below its historical high of $1.25 billion

Market Cap Sector Rank

12.43%
VRAY market capitalization is higher than 12.43% of companies in Healthcare sector

Technical

Beta

-335.00
VRAY beta is -335.00

200-day SMA

$1.97
VRAY price is currently -98.73% below its 200-day simple moving average

14-day RSI

51.52
VRAY 14-day relative strength index is 51.52

30-day Relative Volume

12.01
VRAY 30-day relative volume is 12.01

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$102.21 M
VRAY annual revenue is $102.21 million

Annual Revenue Analysts Estimate

$92.70 M
VRAY annual revenue is currently +10.25% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+45.76%
VRAY annual revenue is up +45.76% year-on-year

Annual Revenue Sector Rank

-
VRAY annual revenue is unknown

Profit

Annual Gross Profit

$10.04 M
VRAY annual gross profit is $10.04 million

Annual Gross Margin

9.83%
VRAY annual gross profit margin is 9.83%

Annual Operating Profit

-$105.31 M
VRAY annual operating income is -$105.31 million

Annual Operating Margin

-103.04%
VRAY annual operating profit margin is -103.04%

Annual Net Income

-$107.33 M
VRAY annual net profit is -$107.33 million

Annual Net Margin

-105.01%
VRAY annual net profit margin is -105.01%

EPS

Annual EPS

-$0.59
VRAY annual earnings per share is -$0.59

Annual EPS Analysts Estimate

-$0.44
VRAY annual earnings per share is currently +34.09% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+11.94%
VRAY annual earnings per share is up +11.94% year-on-year

Annual EPS Sector Rank

-
VRAY annual earnings per share is unknown

ROA & ROE

Annual ROA

-36.19%
VRAY annual return on assets is -36.19%

Annual ROE

-85.17%
VRAY annual return on equity is -85.17%

EBIT & EBITDA

Annual EBIT

-$102.27 M
VRAY annual earnings before interest & taxes is -$102.27 million

Annual EBITDA

-$97.35 M
VRAY annual EBITDA is -$97.35 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
VRAY price to earnings ratio value is unknown

PE Ratio Sector Rank

-
VRAY price to earnings ratio is unknown

PB Ratio

PB Ratio

0.08
VRAY price to book ratio is 0.08

PB Ratio Sector Rank

17.99%
VRAY price to book ratio is higher than 17.99% of companies in Healthcare sector

PS Ratio

PS Ratio

0.04
VRAY price to sales ratio is 0.04

PS Ratio Sector Rank

3.25%
VRAY price to sales ratio is higher than 3.25% of companies in Healthcare sector

Enterprise value

Enterprise Value

$8.43 M
VRAY enterprise value is $8.43 million

Enterprise Value Sector Rank

22.56%
VRAY enterprise value is higher than 22.56% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.08
VRAY EV/EBITDA is -0.08

EV/EBITDA Sector Rank

63.28%
VRAY EV/EBITDA is higher than 63.28% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.36
VRAY annual current ratio is 2.36

Annual Quick Ratio

2.04
VRAY annual quick ratio is 2.04

Leverage

Annual Debt To Equity

0.95
VRAY annual debt to equity ratio is 0.95

Annual Interest Coverage Ratio

-20.22
VRAY annual interest coverage ratio is -20.22

Risk & Stability

Piotroski F-Score

2
VRAY piotroski f-score is 2

Altman Z-Score

-4.63
VRAY altman z-score is -4.63

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$271.40 M
VRAY annual total assets is $271.40 million

Annual Non Current Assets

$43.04 M
VRAY annual long term assets is $43.04 million

Annual Current Assets

$228.35 M
VRAY annual total current assets is $228.35 million

Annual Cash & Cash Equivalents

$135.96 M
VRAY annual cash & cash equivalents is $135.96 million

Equity

Annual Book Value

$82.24 M
VRAY annual book value is $82.24 million

Annual Working Capital

$131.77 M
VRAY annual working capital is $131.77 million

Liabilities

Annual Total Liabilities

$189.16 M
VRAY annual total liabilities is $189.16 million

Annual Total Long Term Liabilities

$92.57 M
VRAY annual total long term liabilities is $92.57 million

Annual Current Liabilities

$96.58 M
VRAY annual total current liabilities is $96.58 million

Annual Accounts Payable

$28.30 M
VRAY annual accounts payable is $28.30 million

Debt

Annual Total Debt

$86.40 M
VRAY annual total debt is $86.40 million

Annual Total Debt 1-Year Change

+27.29%
VRAY annual total debt is up +27.29% year-on-year

Annual Long Term Debt

$83.54 M
VRAY annual long term debt is $83.54 million

Annual Short Term Debt

$2.86 M
VRAY annual short term debt is $2.86 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$207.52 M
VRAY annual total expenses is $207.52 million

Annual Operating Expenses

$115.36 M
VRAY annual total operating expenses is $115.36 million

Annual Cost Of Goods Sold

$92.16 M
VRAY annual cost of goods sold is $92.16 million

Annual SGA

$82.92 M
VRAY annual SGA is $82.92 million

Annual D&A

$4.92 M
VRAY annual depreciation & amortization is $4.92 million

Annual Interest Expense

$5.06 M
VRAY annual interest expense is $5.06 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$91.71 M
VRAY annual cash flow from operations is -$91.71 million

Annual CFO 1-Year Change

-47.7%
VRAY annual cash flow from operations is down -47.7% year-on-year

Annual CFI

-$3.90 M
VRAY annual cash flow from investing activities is -$3.90 million

Annual CFI 1-Year Change

-150.03%
VRAY annual cash flow from investing activities is down -150.03% year-on-year

Annual CFF

$18.29 M
VRAY annual cash flow from financing activities is $18.29 million

Annual CFF 1-Year Change

-85.4%
VRAY annual cash flow from financing activities is down -85.4% year-on-year

Free CashFlow

Annual FCF

-$95.61 M
VRAY annual free cash flow is -$95.61 million

Annual FCF 1-Year Change

-50.21%
VRAY annual free cash flow is down -50.21% year-on-year

CAPEX

Annual CAPEX

$3.90 M
VRAY annual capital expenditures is $3.90 million

Annual CAPEX 1-Year Change

+150.03%
VRAY annual capital expenditures is up +150.03% year-on-year

Institutional Ownership

Similar stocks

SONN logo
Sonnet BioTherapeutics Holdings (SONN)
CHEK logo
Check-Cap (CHEK)
PRTG logo
Portage Biotech (PRTG)
CERO logo
CERo Therapeutics Holdings (CERO)
ADIL logo
Adial Pharmaceuticals (ADIL)
MBIO logo
Mustang Bio (MBIO)
GHSI logo
Guardion Health Sciences (GHSI)
ATIP logo
ATI Physical Therapy (ATIP)
GTBP logo
GT Biopharma (GTBP)

FAQ

  • What is the ticker symbol for ViewRay?
  • Does ViewRay pay dividends?
  • What sector is ViewRay in?
  • What industry is ViewRay in?
  • What country is ViewRay based in?
  • When did ViewRay go public?
  • Is ViewRay in the S&P 500?
  • Is ViewRay in the NASDAQ 100?
  • Is ViewRay in the Dow Jones?
  • When was ViewRay's last earnings report?
  • When does ViewRay report earnings?
  • Should I buy ViewRay stock now?

What is the ticker symbol for ViewRay?

The ticker symbol for ViewRay is NASDAQ:VRAY

Does ViewRay pay dividends?

No, ViewRay does not pay dividends

What sector is ViewRay in?

ViewRay is in the Healthcare sector

What industry is ViewRay in?

ViewRay is in the Medical Devices industry

What country is ViewRay based in?

ViewRay is headquartered in United States

When did ViewRay go public?

ViewRay's initial public offering (IPO) was on August 10, 2015

Is ViewRay in the S&P 500?

No, ViewRay is not included in the S&P 500 index

Is ViewRay in the NASDAQ 100?

No, ViewRay is not included in the NASDAQ 100 index

Is ViewRay in the Dow Jones?

No, ViewRay is not included in the Dow Jones index

When was ViewRay's last earnings report?

ViewRay's most recent earnings report was on Aug 2, 2023

When does ViewRay report earnings?

The date for ViewRay's next earnings report has not been announced yet

Should I buy ViewRay stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions